6533b852fe1ef96bd12aac27

RESEARCH PRODUCT

Pulmonary balloon angioplasty of chronic thromboembolic pulmonary hypertension (CTEPH) in surgically inaccessible cases.

Manfred ThelenMichael B. PittonSascha HerberE. Mayer

subject

AdultMalemedicine.medical_specialtymedicine.medical_treatmentHypertension PulmonaryHemodynamicsEmbolectomyBalloonElectrocardiographyInternal medicineAngioplastyMedicineHumansRadiology Nuclear Medicine and imagingPulmonary Wedge PressureCardiac OutputAgedThrombectomybusiness.industryVascular diseaseContraindicationsRespiratory diseaseAngiographymedicine.diseasePulmonary hypertensionSurgerymedicine.anatomical_structureChronic DiseaseCardiologyVascular resistancebusinessPulmonary EmbolismTomography X-Ray ComputedPerfusionAngioplasty Balloon

description

Abstract The clinical course of patients suffering from chronic thromboembolic pulmonary hypertension (CTEPH) depends on the distribution pattern of the thromboembolic material. In patients with thromboembolic findings in the central pulmonary segments pulmonary thrombendarterectomy (PTE) has excellent results and acceptable operative risk. This paper presents two surgically inaccessible cases that were successfully treated with balloon pulmonary angioplasty. Balloon angioplasty improved parenchymal perfusion, increased cardiac index (Delta CI +19.2 % [Case 1], and +15.4 % [2]), reduced pulmonary vascular resistance during follow-up (Delta PVRI -25.0 % [1] and -15.9 % [2]), and is discussed as an alternative treatment option for cases not suited for surgery.

10.1055/s-2003-39206https://pubmed.ncbi.nlm.nih.gov/12743854